Free Trial

Olema Pharmaceuticals (OLMA) Insider Trading & Ownership

Olema Pharmaceuticals logo
$14.90 -0.23 (-1.52%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$14.84 -0.06 (-0.40%)
As of 05/8/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Olema Pharmaceuticals (NASDAQ:OLMA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
16.36%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$23.21M
Get OLMA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Olema Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OLMA Insider Buying and Selling by Quarter

Olema Pharmaceuticals Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/4/2026
Shawnte Mitchell
Insider
Sell25,000$24.25$606,250.00  
3/3/2026
Shawnte Mitchell
Insider
Sell15,000$23.01$345,150.00  
1/20/2026
Cyrus Harmon
Cyrus Harmon
Director
Sell10,000$26.88$268,800.00  
1/15/2026Sell100,000$28.73$2,873,000.00  
1/14/2026
Cyrus Harmon
Cyrus Harmon
Director
Sell3,489$29.12$101,599.68  
1/13/2026Sell50,000$27.60$1,380,000.00  
1/13/2026Sell3,822$28.01$107,054.22  
1/12/2026Sell10,000$28.34$283,400.00  
12/23/2025Sell99,509$27.66$2,752,418.94  
12/22/2025
Cyrus Harmon
Cyrus Harmon
Director
Sell2,881$28.53$82,194.93  
12/22/2025Sell100,000$28.04$2,804,000.00  
12/19/2025Sell51,000$30.46$1,553,460.00  
12/19/2025
Ian T Clark
Ian T Clark
Director
Sell264,800$29.73$7,872,504.00  
12/19/2025Sell70,000$28.20$1,974,000.00  
9/18/2025
Cyrus Harmon
Cyrus Harmon
Director
Sell10,000$8.33$83,300.00  
9/18/2025
Cyrus Harmon
Cyrus Harmon
Director
Sell3,086$8.32$25,675.52  
9/16/2025
Cyrus Harmon
Cyrus Harmon
Director
Sell10,000$8.04$80,400.00  
9/16/2025
Cyrus Harmon
Cyrus Harmon
Director
Sell1,914$8.08$15,465.12  
(Data available from 1/1/2013 forward)

OLMA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Olema Pharmaceuticals includes Bain Capital Life Sciences Inv, Biocapital Advisors L Paradigm, Bvf Partners L P/Il, Cyrus Harmon, David C Myles, G. Walmsley Graham, Ian T Clark, Naseem Zojwalla, Sean Bohen, Shane William Charles Kovacs, and Shawnte Mitchell. Learn more on insiders at OLMA.

16.36% of Olema Pharmaceuticals stock is owned by insiders. Learn more on OLMA's insider holdings.

The following insider purchased OLMA shares in the last 24 months: Bain Capital Life Sciences Inv ($1,728,000.00).

Insiders have purchased a total of 300,000 OLMA shares in the last 24 months for a total of $1,728,000.00 bought.

The following insiders have sold OLMA shares in the last 24 months: Biocapital Advisors L Paradigm ($35,784,000.00), Cyrus Harmon ($1,270,642.25), David C Myles ($3,333,659.76), G. Walmsley Graham ($4,730,136.75), Ian T Clark ($7,872,504.00), Naseem Zojwalla ($7,530,418.94), Sean Bohen ($490,313.36), Shane William Charles Kovacs ($2,980,054.22), and Shawnte Mitchell ($951,400.00).

Insiders have sold a total of 4,053,364 Olema Pharmaceuticals shares in the last 24 months for a total of $64,943,129.28 sold.



This page (NASDAQ:OLMA) was last updated on 5/10/2026 by MarketBeat.com Staff.
From Our Partners